Literature DB >> 25982787

Successful use of ring pessary with support for advanced pelvic organ prolapse.

Jing Ding1, Chun Chen1, Xiao-Chen Song1, Lei Zhang1, Mou Deng1, Lan Zhu2.   

Abstract

INTRODUCTION AND HYPOTHESIS: Support pessaries are not recommended for patients with advanced prolapse. This study aimed to explore the efficacy of the ring pessary with support for the treatment of advanced pelvic organ prolapse (POP).
METHODS: We conducted this prospective study on pessary fittings performed between November 2013 and September 2014 at the Department of Obstetrics and Gynecology, Peking Union Medical College Hospital (PUMCH), Beijing. A total of 109 patients with stage III or IV POP completed a detailed history. A successful fitting was defined as the continued use of the device for over 3 months from the initial fitting. Data were analyzed with the Wilcoxon rank-sum test, independent sample t tests, continuity correction χ(2) tests, and Fisher's exact test.
RESULTS: A total of 74.3 % (81/109) of the patients were successfully fitted with the ring pessary with support at the initial visit. Among those women with a successful initial fitting, the failure rate was less than 10 % (8/81) at 3 months. Furthermore, 82.7 % (67/81) of the patients were able to manage the pessary by themselves. Seven patients experienced vaginal erosion. There was no association of prolapse stage and the predominant prolapse compartment with pessary trial outcome. The average vaginal length of the patients with successful pessary use was 7.58 cm.
CONCLUSIONS: The ring pessary with support was successfully fitted in patients with advanced POP with a high success rate and few complications. Older patients were more likely to prefer the ring pessary with support due to its convenient use.

Entities:  

Keywords:  Advanced pelvic organ prolapse; Ring pessary with support; Successfully

Mesh:

Year:  2015        PMID: 25982787     DOI: 10.1007/s00192-015-2738-1

Source DB:  PubMed          Journal:  Int Urogynecol J        ISSN: 0937-3462            Impact factor:   2.894


  23 in total

1.  Do pessaries prevent the progression of pelvic organ prolapse?

Authors:  V L Handa; M Jones
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2002-11

2.  Pessary use in pelvic organ prolapse and urinary incontinence.

Authors:  Keisha A Jones; Oz Harmanli
Journal:  Rev Obstet Gynecol       Date:  2010

3.  The standardization of terminology of female pelvic organ prolapse and pelvic floor dysfunction.

Authors:  R C Bump; A Mattiasson; K Bø; L P Brubaker; J O DeLancey; P Klarskov; B L Shull; A R Smith
Journal:  Am J Obstet Gynecol       Date:  1996-07       Impact factor: 8.661

4.  Effect of vaginal pessaries on symptoms associated with pelvic organ prolapse.

Authors:  Ruwan J Fernando; Ranee Thakar; Abdul H Sultan; Sheetle M Shah; Peter W Jones
Journal:  Obstet Gynecol       Date:  2006-07       Impact factor: 7.661

5.  Predictors of successful pessary fitting and continued use in a nurse-midwifery pessary clinic.

Authors:  Jennifer M Maito; Zellisha A Quam; Ellen Craig; Kara A Danner; Rebecca G Rogers
Journal:  J Midwifery Womens Health       Date:  2006 Mar-Apr       Impact factor: 2.388

6.  Vaginal pessaries and their use in pelvic relaxation.

Authors:  P J Sulak; T J Kuehl; B L Shull
Journal:  J Reprod Med       Date:  1993-12       Impact factor: 0.142

7.  Pessary use in advanced pelvic organ prolapse.

Authors:  Kenneth Powers; George Lazarou; Andrea Wang; Julie LaCombe; Giti Bensinger; Wilma M Greston; Magdy S Mikhail
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2005-05-10

Review 8.  Complications of neglected vaginal pessaries: case presentation and literature review.

Authors:  Beatriz E Arias; Beri Ridgeway; Matthew D Barber
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2008-02-27

9.  Predicting treatment choice for patients with pelvic organ prolapse.

Authors:  Michael Heit; Chris Rosenquist; Patrick Culligan; Carol Graham; Miles Murphy; Susan Shott
Journal:  Obstet Gynecol       Date:  2003-06       Impact factor: 7.661

10.  Risk factors associated with an unsuccessful pessary fitting trial in women with pelvic organ prolapse.

Authors:  Jeffrey L Clemons; Vivian C Aguilar; Tara A Tillinghast; Neil D Jackson; Deborah L Myers
Journal:  Am J Obstet Gynecol       Date:  2004-02       Impact factor: 8.661

View more
  7 in total

1.  Discontinuation rate and adverse events after 1 year of vaginal pessary use in women with pelvic organ prolapse.

Authors:  Theerarat Yimphong; Teerayut Temtanakitpaisan; Pranom Buppasiri; Chompilas Chongsomchai; Supparaluck Kanchaiyaphum
Journal:  Int Urogynecol J       Date:  2017-08-16       Impact factor: 2.894

2.  Is it safe and effective to maintain the vaginal pessary without removing it for 2 consecutive years?

Authors:  Alessio Miceli; Manuel Fernández-Sánchez; Juan Polo-Padillo; José-Luis Dueñas-Díez
Journal:  Int Urogynecol J       Date:  2020-02-15       Impact factor: 2.894

3.  Documenting pessary offer prior to hysterectomy for management of pelvic organ prolapse.

Authors:  Anne G Sammarco; Daniel M Morgan; Neil S Kamdar; Carolyn W Swenson
Journal:  Int Urogynecol J       Date:  2018-06-22       Impact factor: 2.894

4.  Effectiveness of a continuous-use ring-shaped vaginal pessary without support for advanced pelvic organ prolapse in postmenopausal women.

Authors:  José Luis Dueñas; Alessio Miceli
Journal:  Int Urogynecol J       Date:  2018-02-24       Impact factor: 2.894

5.  Vaginal Pessaries for Pelvic Organ Prolapse or Stress Urinary Incontinence: A Health Technology Assessment.

Authors: 
Journal:  Ont Health Technol Assess Ser       Date:  2021-05-06

6.  A predictive model of choosing pessary type for women with symptomatic pelvic organ prolapse.

Authors:  Hainan Xu; Wenjing Wu; Xinlu Wang; Zhijun Xia
Journal:  Menopause       Date:  2021-10-11       Impact factor: 3.310

Review 7.  Parameters associated with unsuccessful pessary fitting for pelvic organ prolapse up to three months follow-up: a systematic review and meta-analysis.

Authors:  Claudia Manzini; Lisan M Morsinkhof; C Huub van der Vaart; Mariëlla I J Withagen; Anique T M Grob
Journal:  Int Urogynecol J       Date:  2022-01-17       Impact factor: 1.932

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.